PRESS RELEASE published on 12/23/2024 at 06:30, 1 year 4 months ago Siegfried once again confirmed in the Dow Jones Sustainability Index Europe Siegfried AG confirmed in Dow Jones Sustainability Index Europe for fourth consecutive year, signaling strong ESG performance and commitment to sustainability Sustainability ESG Performance Siegfried AG Dow Jones Sustainability Index Europe Siegfried Group
BRIEF published on 12/06/2024 at 06:35, 1 year 5 months ago Changes in Siegfried AG's Executive Leadership Growth Strategy Pharmaceutical Industry Executive Changes Leadership Roles Siegfried AG
BRIEF published on 12/06/2024 at 06:35, 1 year 5 months ago Changements dans la direction de Siegfried AG Stratégie De Croissance Industrie Pharmaceutique Siegfried AG Changements Exécutifs Rôles De Direction
PRESS RELEASE published on 12/06/2024 at 06:30, 1 year 5 months ago Changes in Siegfried's senior management team Siegfried AG announces changes in senior management team, including new Chief Scientific Officer, Chief Human Resources Officer, and Chief Legal and Sustainability Officer Chief Scientific Officer Senior Management Team Siegfried AG Chief Human Resources Officer Chief Legal And Sustainability Officer
BRIEF published on 11/19/2024 at 07:08, 1 year 5 months ago Siegfried ouvre un nouveau centre de recherche et développement de substances médicamenteuses à Evionnaz Industrie Pharmaceutique Siegfried AG Substances Médicamenteuses Evionnaz Centre De R&D
BRIEF published on 11/19/2024 at 07:08, 1 year 5 months ago Siegfried Opens New R&D Center for Drug Substances in Evionnaz Pharmaceutical Industry Siegfried AG Drug Substances R&D Center Evionnaz
PRESS RELEASE published on 11/19/2024 at 07:03, 1 year 5 months ago Siegfried opens new global R&D Center for Drug Substances in Evionnaz Siegfried inaugurates new R&D Center for Drug Substances in Evionnaz, Switzerland, enhancing global development capabilities and supporting EVOLVE+ strategy Pharmaceutical Industry Drug Substances Siegfried R&D Center Evionnaz
BRIEF published on 11/12/2024 at 06:35, 1 year 5 months ago DINAMIQS s'agrandit avec un nouveau laboratoire à Zurich Thérapie Cellulaire Et Génique Bio-Technopark Zurich Laboratoire DINAMIQS Extension Siegfried Fabrication De Vecteurs Viraux
BRIEF published on 11/12/2024 at 06:35, 1 year 5 months ago DINAMIQS Expands with New Lab in Zurich Cell And Gene Therapy DINAMIQS Lab Siegfried Expansion Viral Vector Manufacturing Bio-Technopark Zurich
PRESS RELEASE published on 11/12/2024 at 06:30, 1 year 5 months ago DINAMIQS opens new lab in Zurich Siegfried's subsidiary DINAMIQS opens new state-of-the-art lab in Zurich Bio-Technopark, strengthening offerings in cell and gene therapy market Cell And Gene Therapy Zurich Siegfried DINAMIQS Lab
Published on 05/09/2026 at 01:30, 1 day 6 hours ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 1 day 8 hours ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/09/2026 at 19:05, 13 hours 10 minutes ago LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 1 day 11 hours ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 1 day 13 hours ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 1 day 13 hours ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 2 days 13 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 2 days 13 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 2 days 13 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 2 days 13 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 2 days 13 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
